4DX
Director Trades
| Date | Director | Value |
|---|
Company News

4DMedical Extends Imaging Technology into Public Hospitals and National Screening Network
4DMedical (ASX: 4DX) has secured three significant agreements to expand the reach of its lung health imaging technology. In Australia, 4DMedical has locked in a multi-year deal with Spectrum Medical Imaging to support the National Lung Cancer Screening Program. The company will also launch a Brazilian lung screening program with a leading pharmaceutical partner, while […]

4DMedical Secures US Medicare Reimbursement Approval for CT:VQ Imaging Software
4DMedical (ASX: 4DX) has received reimbursement approval from the US Centers for Medicare & Medicaid Services (CMS) for its CT:VQ lung imaging platform. The decision follows Food and Drug Administration (FDA) clearance granted last week, aligning regulatory authorisation with a defined payment structure. Together, the approvals clear the path for commercial rollout of the software […]

4DMedical Gains FDA Clearance For Groundbreaking CT:VQ Imaging Software
4DMedical (ASX: 4DX) has received United States Food and Drug Administration (FDA) clearance for its CT:VQ software, marking a major milestone in respiratory diagnostics. The technology is the world’s first non-contrast CT-based ventilation-perfusion tool to replace nuclear medicine scans currently used to assess airflow and blood flow in the lungs. The clearance opens a potential […]

4DMedical analytical software to be used by industry partners to help advance new lung disease therapies
4DMedical (ASX: 4DX) will lend its ground-breaking analytical software to two industry partners working to bring new lung disease therapies to market. US-based SMS Biotech will use the company’s suite of software tools for a trial of its novel human stem cell therapy for the treatment of chronic obstructive pulmonary disease (COPD) and an undisclosed […]

4DMedical wins contract to supply lung imaging technology to US radiology company
4DMedical (ASX: 4DX) has been awarded a contract with US-based Imaging Partners of Orange County (IPOC) to provide computed tomography (CT) scans for lung ventilation (LVAS) and lung density (LDAf) analysis. The contract – the term of which extends through March, 2026 – reflects accelerated progress in the commercialisation of 4DMedical’s lung imaging technology and […]

Weekly wrap: shares rise to a record high on mining optimism
Australian shares just managed to seal a record closing high on Friday, with a strong rally in mining shares managing to offset losses in almost every other sector. By the close of trade, the ASX 200 was up a slim 8.5 points or 0.1% to 8212.2 points, with the index closing just above flat for […]

4DMedical expands US market reach through strategic distribution agreement with Philips
4DMedical (ASX:4DX) has signed what it sees as a transformational distribution agreement that will provide it with further access to US markets. The respiratory imaging technology specialist has expanded on a previous agreement with leading global healthcare company Koninklijke Philips (Philips), which will now become an authorised reseller across the United States. 4DMedical announced in […]

4DMedical lung scan procedure to be included in US reimbursement program
Respiratory imaging technology company 4DMedical (ASX: 4DX) has confirmed that its XV LVAS procedure is to be included in a key medical treatment reimbursement program in the United States. From 1 January 2024, XV LVAS scans conducted in a US hospital outpatient facility for Medicare patients will be able to be billed to the US […]

4DMedical signs deal to supply lung imaging technology to Australian radiology clinics
Respiratory device specialist 4DMedical (ASX: 4DX) has signed a deal with I-MED Radiology Network (I-MED) to supply its industry-first lung imaging technology to more than 250 clinics throughout Australia. The three-year agreement clears the way for 4D’s XV Technology and Lung Ventilation Analysis Software (XV LVAS) to be delivered to I-MED clinics in Sydney, Melbourne, […]

Diagnostic imaging: which stock will become the next Pro Medicus?
For all the leaps and bounds in medical science, the know-how behind detecting diseases hasn’t changed much in decades – or even centuries. Take X-rays, which are widely used despite the wee problem of irradiating the patients. And that’s because they are cheap and convenient. The underlying tech hasn’t really moved on since 1895, when […]
Company Videos
No videos found.